H1-0 and cancer: Out of the total 83 serum samples from cancer patients, 54 (65.06%) exhibited appreciably higher binding with MG-H1as against its native counterpart, thus exhibiting better recognition for the modified histone H1 by cancer autoantibodies.Sera from normal human subjects did not show appreciable binding with histones H1 in either of its native or modified form.